deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT03576313

Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination (MASSIV)

Sponsor: Imperial College London

Conditions Malaria
Interventions dihydroartemisinin-piperaquine (DP) ivermectin (IVM) standard malaria control interventions only
Updated 9 times since 2018 Last updated: Mar 11, 2022 Started: Aug 11, 2018 Primary completion: Dec 31, 2019 Completion: Jul 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Malaria, this trial is completed. The trial is conducted by Imperial College London and has accumulated 9 data snapshots since 2018. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Aug 2018 – ~Dec 2018 · 4 months · monthly snapshotNot Yet Recruiting~Dec 2018 – ~Apr 2020 · 16 months · monthly snapshotRecruiting~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Mar 2022 · 14 months · monthly snapshotActive Not Recruiting~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshotActive Not Recruiting~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Apr 2022 — Jul 2024 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  5. Mar 2022 — Apr 2022 [monthly]

    Active Not Recruiting PHASE3

▶ Show 4 earlier versions

  1. Jan 2021 — Mar 2022 [monthly]

    Active Not Recruiting PHASE3

  2. Apr 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  3. Dec 2018 — Apr 2020 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  4. Aug 2018 — Dec 2018 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Imperial College London
  • Institute of Tropical Medicine, Belgium
  • Liverpool School of Tropical Medicine
  • London School of Hygiene and Tropical Medicine
  • National Malaria Control Programme, The Gambia
  • Radboud University Medical Center
  • University of Durham
Data source: London School of Hygiene and Tropical Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations